Home › Lymphoma › Minnesota › Rochester

Pag-aaral pangklinika para sa Lymphoma sa Rochester, MN

Isang pag-aaral para sa Lymphoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Rochester. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Nagre-recruitPhase 3

Mayo Clinic Rochester, Rochester

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07188558

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Nagre-recruitPhase 1/2

Mayo Clinic, Clinical Trials Referral Office, Rochester

Edad 13 hanggang 90 · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT06533579

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

Nagre-recruitPhase 1/2

Mayo Clinic, Rochester

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 6, 2026 · NCT03328078

Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)

Nagre-recruitPhase 3

Research Site, Rochester

Edad 18 hanggang 18 · Lahat ng kasarian · Na-update Okt 6, 2026 · NCT07509151

Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia

Nagre-recruitPhase 2

Mayo Clinic in Rochester, Rochester

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT03418038

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

Nagre-recruitPhase 1/2

Mayo Clinic, Rochester

Edad 12 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT04588922

DALY II USA/ MB-CART2019.1 for DLBCL

Nagre-recruitPhase 2

Mayo Clinic, Rochester

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 13, 2026 · NCT04792489

Dietary and Topical Magnesium Replacement or Supplementation in Patients With Lymphoma

Nagre-recruitMaagang Phase 1Malugod na tinatanggap ang malusog na boluntaryo

Mayo Clinic in Rochester, Rochester

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 16, 2026 · NCT05294367

BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma

Nagre-recruitPhase 2

Mayo Clinic, Rochester

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 20, 2026 · NCT06854003

WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring)

Nagre-recruit

Mayo Clinic in Rochester, Rochester

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 15, 2025 · NCT07058064

Pag-aaral para sa Lymphoma sa ibang lungsod

Iba pang pag-aaral sa Rochester

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.